FDA Says Yes to Cryoablation for Early Breast Cancer

FDA Says Yes to Cryoablation for Early Breast Cancer

(MedPage Today) -- The FDA granted marketing authorization for the ProSense Cryoablation System for small, early-stage breast cancer in older women not suitable for surgery, maker IceCure announced. A minimally invasive tool that destroys tumors...

FDA Grants De Novo Approval for Cryoablation Treatment of Breast Cancer

In a multicenter trial, researchers found 96.3 percent of women with low-risk, early-stage breast cancer had no local recurrence after being treated with a combination of ProSense cryoablation and hormone therapy.